APYX
Apyx Medical Corporation Common StockRecent alerts on APYX
All signals →
SEC filing
APYX Reports New Study Showing 81.8% Improvement in Cellulite Appearance with Avéli and Renuvion Treatment, Demonstrating Measurable Reductions in Dimple Volume and Increased Collagen/Elastin
11d ago
News
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
14d ago
SEC filing
Other Events
19d ago
SEC filing
APYX Reports $12.5M Q1 Rev, $2.1M Net Loss, Raises FY2026 Rev Guidance to $59-60M, +36% YoY Surgical Aesthetics Growth, +62.9% Intl Sales Surge, Renuvion Wins 2026 NewBeauty Award
26d ago
News
Apyx Medical outlines 9%–11% revenue growth target for 2026 as AYON launch accelerates
84d ago
News
Apyx Medical reports preliminary Q4 revenue up about 34%
141d ago
News
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
156d ago
Get push alerts for APYX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS